Can a tube be inserted through the nostril into the lungs for anti-inflammatory treatment?

Generally, inserting a tube through the nostril into the lungs for anti-inflammatory treatment is feasible in specific cases of lung infection, but it is not suitable when there is no infection or when airway procedures are contraindicated. If in doubt, it is recommended to consult a healthcare professional in advance. Detailed analysis is as follows:

This method usually involves transnasal tracheal intubation or drug delivery via bronchoscopy. It is used for severe lung infections or conditions involving poor sputum drainage, allowing anti-inflammatory medications to be delivered directly to the infected site for precise therapeutic effects. It also helps clear airway secretions, improve ventilation, and promote recovery.

If there is no definite lung infection requiring anti-inflammatory treatment, or if conditions such as severe nasal or airway deformities or coagulation disorders exist, this procedure may damage the airway mucosa, cause bleeding, or lead to the spread of infection, making it inappropriate. Mild lung infections can typically be managed with oral or intravenous medications, without the need for invasive procedures.

The decision to use this approach must be made by a physician after a comprehensive evaluation of the patient's condition; patients should not request it on their own. After the procedure, patients must follow medical instructions for airway care and closely monitor their respiratory status. Any adverse symptoms such as hemoptysis (coughing up blood) or difficulty breathing should be promptly reported to healthcare providers for timely management, ensuring safe and effective treatment.